Source recordFED

Sefton, Michael V

Federal grants & contributions· Canadian Institutes of Health Research· FY2017· $235,413· ON

Description

Vascularized regenerative biomaterials for medical devices and cell therapy

Amendment chain · 1 entry

Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.

$235,413$0Original · 2016-04-01 (start date) · total $235,413
  • #02016-04-01$235,413
RowDateTotal value as of rowChange vs previousDescription on this row
#0 original2016-04-01(start date)$235,413—Vascularized regenerative biomaterials for medical devices and cell therapy

Related records · 2

Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).

Other current agreements for the same recipient (exact legal name match; no business number on file)

RefDepartment · programCurrent valueFY
236-2017-2018-Q2-00248Canadian Institutes of Health Research | Instituts de recherche en santé du Canada$844,003FY2018
236-2015-2016-Q2-00805Canadian Institutes of Health Research | Instituts de recherche en santé du Canada$619,244FY2016

Cite as: Glassbox record view · Federal grants & contributions · 236-2016-2017-Q1-00262 · retrieved 2026-11-14.